Tag: hemodialysis

Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023

Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023 aXess demonstrated exceptional patency rates and no infections to date EINDHOVEN, The Netherlands – 17 November 2023, Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces […]

CorMedix Inc. Announces FDA Approval of DefenCath® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients

– First and only FDA-approved antimicrobial catheter lock solution in the U.S. – Company expects DefenCath to be available in Q1 2024 in the inpatient setting BERKELEY HEIGHTS, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for […]

TVA Medical Release: Meta-Analysis Demonstrates Positive Clinical Experience Using everlinQ™ endoAVF System for Hemodialysis Acces

Results from 236 patients across 28 sites in seven countries presented at LINC 2018 support growing body of evidence for pioneering clinical approach [01-February-2018] LEIPZIG, Germany, Feb. 1, 2018 /PRNewswire/ — An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for hemodialysis access was […]

Laminate Medical Technologies Receives IDE Approval From FDA To Initiate Clinical Study Of The VasQ Device

TEL AVIV, Israel–(BUSINESS WIRE)–Laminate Medical Technologies (Laminate), an Israeli biomedical start-up developing VasQ, an implanted blood vessel external support device for patients requiring arteriovenous fistula as vascular access for hemodialysis, today announced that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA). IDE approval […]

TVA Medical Release: Study Published In Prominent Journal Supports Use Of Innovative Endovascular Hemodialysis Access Technology

AUSTIN, Texas, June 15, 2017/PRNewswire/ — TVA Medical, Inc. today announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQTM endoAVF System. The 12-month data published online in the American Journal of Kidney Diseases (AJKD), the official journal of the National Kidney Foundation, […]